S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B. (23rd June 2022) - Tobiasson, M.; Pandzic, T.; Illman, J.; Nilsson, L.; Weström, S.; Sollander, K.; Ejerblad, E.; Olsnes Kittang, A.; Olesen, G.; Werlenius, O.; Björklund, A.; Wiggh, J.; et al.